Clene Inc. ( NASDAQ : CLNN )

Sector: Healthcare   |   Industry: Biotechnology
Pre-Market Intra-Day After-Hours
3.29
( +0.01 / +0.30% )
4.14
( +0.86 / +26.22% )
—
15-Sep 09:19 15-Sep 15:20 14-Sep 17:52
Previous Close 3.28 52-Week Low 3.26
Open 3.48 52-Week High 13.50
Day Low 3.48 50-Day Average 4.89
Day High 4.18 200-Day Average 5.65
Volume 418.52 K Market Cap 52.84 M
News Chart Press Release Analysis Earnings Outlooks Ratings Dividends Upcoming Catalysts

Press Releases - CLNN

Latest press releases and announcements for CLNN .

Reset
Showing 1 – 1 of 1 press releases for CLNN from 2026-09-15 to 2026-09-15
15-Sep-2026 09:00
CLNN
Clene Announces $4 Million Registered Direct Offering
GlobeNewsWire
Investment led by Clene's Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene's Chief Executive Officer and other existing shareholders $4 million registered direct offering priced at market under Nasdaq rules Proceeds are expected to be sufficient to fund the Company to mid-first quarter 2027 SALT LAKE CITY, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), a clinical-stage biotechnology company focused on ALS, today announced the pricing of a registered direct offering of 1,219,513 shares at a purchase price of $3.28 per share to existing shareholders, including insiders, with total gross proceeds of $4 million.